Amazon Web Services and Memorial Sloan Kettering Partner to Advance Cancer Treatment and Research
New York, NY – February 14, 2023 – Amazon Web Services (AWS) and Memorial Sloan Kettering (MSK) announced a new partnership today to develop a comprehensive data resource and AI-powered tools for cancer research and patient treatment personalization.
This collaboration aims to create a high-quality longitudinal data resource that will facilitate the validation and improvement of cancer research outcomes. By leveraging AWS's AI capabilities, MSK researchers and clinicians can gain insights into disease progression and tailor treatments based on individual patient profiles.
"This partnership will enable us to enhance our cancer research capabilities and provide more personalized care for our patients," said Dr. Anaeze Offodile II, Chief Strategy Officer at MSK. "By leveraging the combined expertise of AWS and MSK, we can accelerate the development of new therapies and improve patient outcomes."
AWS has been actively expanding its partnerships in the healthcare industry. In collaboration with GE HealthCare (GEHC), the company has developed X-ray and MRI models. AWS remains committed to advancing AI innovation in healthcare through strategic partnerships with leading healthcare providers and researchers.
"We are excited to partner with MSK to drive advancements in cancer care," said Matt Wood, Vice President of Healthcare and Life Sciences at AWS. "AWS's AI and cloud capabilities will empower MSK to make data-driven decisions, improve patient outcomes, and ultimately help shape the future of healthcare."
This partnership marks a significant step forward in the integration of AI and cloud computing in cancer research and treatment. AWS and MSK believe that by leveraging their combined strengths, they can unlock new possibilities in precision medicine and improve the lives of patients worldwide.